MACQUARIE GROUP LTD - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,000
+100.0%
0
-100.0%
0.00%
Q2 2022$2,000
-33.3%
1160.0%0.00%
Q1 2022$3,0000.0%1160.0%0.00%
Q4 2021$3,0000.0%1160.0%0.00%
Q3 2021$3,000
-25.0%
1160.0%0.00%
Q2 2021$4,0000.0%1160.0%0.00%
Q1 2021$4,000
-20.0%
116
-32.2%
0.00%
Q4 2020$5,000
-16.7%
1710.0%0.00%
Q3 2020$6,000
-25.0%
1710.0%0.00%
Q2 2020$8,000
-91.8%
171
-94.1%
0.00%
Q1 2020$98,0002,8760.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders